IGF-1Lr3 1MG
$99.00
IGF-1Lr3 1MG is a 1-milligram format of Long R3 IGF-1, a modified insulin-like growth factor 1 analogue used in laboratory research. It features an Arg3 substitution and an N-terminal extension that researchers study for altered receptor binding and reduced interaction with IGF binding proteins. Studies have examined IGF-1Lr3 in cell culture work involving growth-factor signaling and metabolism-related pathways.
In Stock
IGF-1Lr3 1MG is a 1-milligram format of Long R3 insulin-like growth factor 1, a recombinant IGF-1 analogue commonly used in research settings. The IGF-1Lr3 design includes an Arg substitution at position 3 and an extended N-terminus, modifications researchers use when investigating changes in IGF receptor engagement and binding-protein interactions.
In vitro studies have examined IGF-1Lr3 in the context of cell proliferation assays, differentiation models, and signal transduction experiments where IGF-1 pathways are of interest. Researchers may compare IGF-1Lr3 1MG with native IGF-1 across experimental systems to evaluate differences in potency, stability, and binding dynamics under controlled conditions.
- Specification: 1MG
- Molecular Formula: C990H1528N262O299S7
- Molecular Weight: 9111.00 g/mol
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
MT-2 Melanotan II Acetate 10MG is a 10-milligram format of melanotan II, a synthetic melanocortin peptide analogue related to alpha MSH. Researchers study it for its potential interaction with melanocortin receptors and downstream signaling in pigmentation and appetite models. Studies have also examined MT-2 Melanotan II Acetate 10MG in broader neuroendocrine research contexts.
In Stock
NAD 100MG is a 100-milligram format of nicotinamide adenine dinucleotide (NAD+), a ubiquitous pyridine nucleotide that participates in cellular redox reactions. Researchers study NAD+ in the context of mitochondrial metabolism, oxidative stress models, and enzyme systems such as sirtuins and PARPs.
In Stock
CJC 1295 With DAC 5MG is a 5-milligram format of CJC-1295 with drug affinity complex (DAC), a synthetic growth hormone releasing hormone analogue peptide. Researchers study this modified GHRH fragment for its potential to extend peptide half life through albumin binding. Studies have examined CJC 1295 With DAC 5MG in preclinical and investigational settings focused on pulsatile GH signaling and IGF 1 related endpoints.
In Stock
Glutathione 1500MG is a 1500-milligram format of glutathione, a naturally occurring tripeptide made of glutamate, cysteine, and glycine. Researchers study glutathione in the context of cellular redox balance and antioxidant systems. It is also investigated in models involving detoxification pathways and oxidative stress biology.
In Stock
SS-31 50MG is a 50-milligram format of SS-31, a synthetic tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential to localize to mitochondria and for its use in preclinical models examining mitochondrial membrane and bioenergetic pathways.
In Stock
GHK-Cu + TB-500 + BPC-157 + KPV 80MG is an 80-milligram multi-peptide blend combining a copper tripeptide complex with three commonly studied synthetic peptides. Researchers investigate these components in preclinical and in vitro work related to extracellular matrix biology, cell migration signaling, and tissue model recovery. Studies have also examined GHK-Cu, TB-500, BPC-157, and KPV in contexts involving inflammatory signaling pathways and barrier integrity models.
In Stock
SS-31 10MG is a 10-milligram format of SS-31, a synthetic mitochondria targeted tetrapeptide also known as elamipretide. Researchers study SS-31 for its potential interactions with cardiolipin and mitochondrial membrane function in preclinical models. Studies have examined SS-31 in cellular and animal research involving bioenergetics and oxidative stress pathways.
In Stock
Methenolone Enanthate – 100mg/ml, 10ml is a specified concentration and volume format of methenolone enanthate, an enanthate ester of methenolone, a synthetic anabolic androgenic steroid derivative of dihydrotestosterone. Researchers study methenolone esters in analytical and receptor binding work involving androgen signaling. It is also examined in methods development for steroid profiling and reference comparisons.
In Stock
BPC-157 + GHK-GHK-Cu + TB-500 50MG is a 50-milligram combination format bringing together three widely studied research peptides used in preclinical recovery and tissue-model work. Researchers investigate BPC-157, a 15 amino acid peptide fragment, alongside the copper binding GHK tripeptide motif and TB-500, a thymosin beta 4 analogue fragment, in models involving connective tissue, angiogenesis signaling, and cellular migration pathways.
In Stock
Methenolone Enanthate 200mg/ml 10ml is a 17 beta esterified derivative of methenolone, an anabolic androgenic steroid related to dihydrotestosterone. Researchers have examined methenolone enanthate in studies involving androgen receptor activity, anabolic androgenic structure activity relationships, and ester dependent pharmacokinetics.
In Stock
Metribolone 5mg/ml 10ml is a concentration and volume format of metribolone, a synthetic anabolic androgenic steroid also known as R1881. Researchers use metribolone as a high affinity androgen receptor agonist reference compound in receptor binding and transcriptional activity studies. It is commonly handled as a laboratory standard in endocrine and molecular pharmacology research.
In Stock
MOTS-C 40MG is a 40-milligram format of MOTS-c, a 16 amino acid mitochondrial derived peptide encoded within mitochondrial 12S rRNA. Researchers study MOTS-c for its potential role in cellular stress responses and metabolic signaling in preclinical models. Interest also includes how this peptide may interact with exercise related pathways and adaptive physiology.
In Stock
